MedPath

Comparing the Effect of Lavender and Rosemary Essential Oil Inhalation and the Simultaneous Use of These Two Scents on Sleep Quality, Anxiety and Depression in Patients Suffering from Coronary Artery Disease

Not Applicable
Recruiting
Conditions
Coronary Artery disease.
Ischaemic heart diseases
I20-I25
Registration Number
IRCT20230702058649N1
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
148
Inclusion Criteria

Being diagnosed with coronary artery Disease
Having no history of neuropsychiatric disease by self report
Having no history of taking psychiatric medications
Normal olfactory function
Not using benzodiazepines, sedatives and narcotics
No history of asthma
No history of allergies to plants or any seasonal allergies
Absence of severe pain causes sleep disturbance
Obtaining scores of greater than five from the PSQI Sleep quality questionnaire
Having an ejection fraction above 45%
Being able to read and write
Access to social media

Exclusion Criteria

Acute pain at the time of completing the questionnaire
Any case that causes olfactory disorders during study
Showing an allergic reaction to the smell of essential oils
Showing discomfort with the smell of essential oils
Occurrence of life-threatening complications such as cardiopulmonary resuscitation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression score in Cardiac Depression Scale (CDS). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Cardiac Depression Scale (CDS).;Anxiety score in Hospital Anxiety and Depression Scale (HADS ). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Hospital Anxiety and Depression Scale (HADS ).;Sleep quality score in Pittsburgh Sleep Quality Index (PSQI). Timepoint: Before the intervention, 14 and 30 days after the start of the intervention. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath